Assignee
NOXXON PHARMA AG
DE·22 granted patents·20 pending applications·116 citations·filing 2001–2022
Top patents by PatentIndex Score
42 records- 0189US8367629B2MCP-1 binding nucleic acids and use thereofNOXXON PHARMA AG·Filed 2008·Granted Feb 5, 2013·6 cites·14 claims
- 0289US7629456B2Modified L-nucleic acidNOXXON PHARMA AG·Filed 2002·Granted Dec 8, 2009·31 cites·20 claims
- 0385US9518265B2C5a binding nucleic acidsNOXXON PHARMA AG·Filed 2013·Granted Dec 13, 2016·6 cites·12 claims
- 0484US9387221B2SDF-1 binding nucleic acids and the use thereof in cancer treatmentNOXXON PHARMA AG·Filed 2015·Granted Jul 12, 2016·2 cites·20 claims
- 0584US6534271B2Cloning and copying on surfacesNOXXON PHARMA AG·Filed 2001·Granted Mar 18, 2003·28 cites·22 claims
- 0683US7879991B2CGRP binding nucleic acidsNOXXON PHARMA AG·Filed 2003·Granted Feb 1, 2011·21 cites·25 claims
- 0780US9035038B2SDF-1 binding nucleic acidsNOXXON PHARMA AG·Filed 2012·Granted May 19, 2015·3 cites·18 claims
- 0878US10093934B2SDF-1 binding nucleic acids and the use thereof in cancer treatmentNOXXON PHARMA AG·Filed 2016·Granted Oct 9, 2018·1 cites·18 claims
- 0978US9850471B2Enzymatic synthesis of L-nucleic acidsNOXXON PHARMA AG·Filed 2013·Granted Dec 26, 2017·3 cites·13 claims
- 1078US7750140B2Ghrelin binding nucleic acidsNOXXON PHARMA AG·Filed 2003·Granted Jul 6, 2010·11 cites·18 claims
- 1175US11371045B2Method of modulating the number and the distribution of tumor-infiltrating leukocytes in tumorsNOXXON PHARMA AG·Filed 2017·Granted Jun 28, 2022·1 cites·17 claims
- 1273US9988636B2SDF-1 binding nucleic acids and the use thereofNOXXON PHARMA AG·Filed 2016·Granted Jun 5, 2018·1 cites·14 claims
- 1372US11492625B2C5a binding nucleic acidsNOXXON PHARMA AG·Filed 2020·Granted Nov 8, 2022·0 cites·19 claims
- 1471US2021139909A1SDF-1 Binding Nucleic AcidsNOXXON PHARMA AG·Filed 2020·Application pending·0 cites
- 1570US9163243B2Nucleic acids specifically binding CGRPNOXXON PHARMA AG·Filed 2013·Granted Oct 20, 2015·2 cites·24 claims
- 1667US2020010833A1Modified L-Nucleic AcidNOXXON PHARMA AG·Filed 2019·Application pending·0 cites
- 1767US2010081710A1Modified L-Nucleic AcidNOXXON PHARMA AG·Filed 2009·Application pending·0 cites
- 1867US2023146246A1Method of Modulating the Number and the Distribution of Tumor-Infiltrating Leukocytes in TumorsNOXXON PHARMA AG·Filed 2022·Application pending·0 cites
- 1964US2010062436A1Methods for Detection of a Single- or Double-Stranded Nucleic Acid MoleculeNOXXON PHARMA AG·Filed 2007·Application pending·0 cites
- 2063US9670491B2MCP-1 binding nucleic acidsNOXXON PHARMA AG·Filed 2014·Granted Jun 6, 2017·0 cites·17 claims
- 2163US2015038562A1Modified L-nucleic AcidNOXXON PHARMA AG·Filed 2014·Application pending·0 cites
- 2263US2018179541A1Modified L-Nucleic AcidNOXXON PHARMA AG·Filed 2018·Application pending·0 cites
- 2362US10273480B2MCP-1 binding nucleic acidsNOXXON PHARMA AG·Filed 2017·Granted Apr 30, 2019·0 cites·20 claims
- 2461US10590424B2C5a binding nucleic acidsNOXXON PHARMA AG·Filed 2016·Granted Mar 17, 2020·0 cites·17 claims
- 2560US2018163207A1SDF-1 Binding Nucleic AcidsNOXXON PHARMA AG·Filed 2017·Application pending·0 cites
- 2658US9822369B2SDF-1 binding nucleic acidsNOXXON PHARMA AG·Filed 2015·Granted Nov 21, 2017·0 cites·14 claims
- 2758US2016376594A1Modified L-Nucleic AcidNOXXON PHARMA AG·Filed 2016·Application pending·0 cites
- 2858US2010311816A1MCP-1 binding nucleic acids and use thereofNOXXON PHARMA AG·Filed 2008·Application pending·0 cites
- 2957US2014370034A1SDF-1 Binding Nucleic Acids and the Use ThereofNOXXON PHARMA AG·Filed 2014·Application pending·0 cites
- 3056US9074214B2Use of spiegelmersNOXXON PHARMA AG·Filed 2013·Granted Jul 7, 2015·0 cites·22 claims
- 3152US2007031840A1Nucleic acids specifically binding bioactive ghrelinNOXXON PHARMA AG·Filed 2004·Application pending·0 cites
- 3250US2016257958A1Hepcidin Binding Nucleic AcidsNOXXON PHARMA AG·Filed 2014·Application pending·0 cites
- 3349US2019367921A1Nucleic acid molecule having binding affinity to a target molecule and a method for generating the sameNOXXON PHARMA AG·Filed 2018·Application pending·0 cites
- 3448US2011027794A1Method for Synthesizing Nucleic Acids, and Application ThereofNOXXON PHARMA AG·Filed 2010·Application pending·0 cites
- 3547US11459352B2Method for polyalkoxylation of nucleic acids that enables recovery and reuse of excess polyalkoxylation reagentNOXXON PHARMA AG·Filed 2017·Granted Oct 4, 2022·0 cites·23 claims
- 3647US2003219422A1Allosteric ribozymes and uses thereofNOXXON PHARMA AG·Filed 2002·Application pending·0 cites
- 3746US2017233737A1Means and Methods for the Treatment of NephropathyNOXXON PHARMA AG·Filed 2014·Application pending·0 cites
- 3843US2015232852A1Glucagon Binding Nucleic AcidsNOXXON PHARMA AG·Filed 2012·Application pending·0 cites
- 3942US2010261291A1Nucleic acids specifically binding bioactive ghrelinNOXXON PHARMA AG·Filed 2010·Application pending·0 cites
- 4040US10513536B2Methods for the preparation of a polyalkoxylated nucleic acid moleculeNOXXON PHARMA AG·Filed 2015·Granted Dec 24, 2019·0 cites·17 claims
- 4140US8383789B2Vasopressin-binding L-nucleic acidNOXXON PHARMA AG·Filed 2005·Granted Feb 26, 2013·0 cites·18 claims
- 4238US2011229976A1Sequencing of nucleic acid molecules by mass spectrometryNOXXON PHARMA AG·Filed 2009·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when NOXXON PHARMA AG files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →